In Practice: AI for Life Sciences
Patlytics is bringing life sciences IP leaders together to share how AI is changing the way they read the biosimilar patent landscape.
Save your seat
Register to join live or receive the recording afterward.
For biologics, loss of exclusivity rarely hinges on a single patent, and brand and biosimilar teams both need to see the whole landscape and move quickly. Outside counsel from Mintz and in-house counsel from Novo Nordisk will share what has changed in their process since bringing in AI, where it has made the biggest difference, and what they would tell teams just getting started.
“Beyond the Composition of Matter: AI and the Biosimilar Patent Landscape”
Panel discussion with audience Q&A.
About 60 minutes.
End-to-end lifecycle support
From prep and prosecution through invalidity, infringement, FTO and licensing — one platform across every stage.
International coverage
Search and analysis across US, EP, KR, JP, WO, TW and CN filings, backed by a 130M+ patent database.
Agentic AI, with attorney in control
Patlytics Agent runs inside every module, with citation-backed output your team reviews and approves.
Edmund Koundakjian, J.D., Ph.D., is a Patent Attorney at Mintz in San Diego, where he focuses on U.S. and international patent prosecution and strategic IP counseling for life sciences and biotechnology clients. His work includes freedom-to-operate, patentability, invalidity and portfolio analyses, as well as IP diligence on biotech financings, including public offerings and private placements. Before practicing as an attorney, he spent more than eight years as a patent agent at Am Law 100 firms. Edmund holds a Ph.D. in Neurobiology from Harvard University, where he researched genes regulating inner ear nerve development and received an NIH Ruth L. Kirschstein National Research Service Award. He began his career as a research technician in a Howard Hughes Medical Institute lab at UC San Diego, and earned his J.D. from Suffolk University Law School.
Sunny Malhotra, Ph.D., J.D., is Senior Intellectual Property Counsel at Novo Nordisk. He brings a scientific foundation to his IP work, having earned his Ph.D. at Johns Hopkins University, where his research focused on cancer genetics and was published in journals including PLOS Pathogens and the Journal of Virology. He received his J.D. from New England Law | Boston.
Candice Kwark is Legal Engineer & IP Counsel at Patlytics, where she brings a practitioner’s lens to how IP teams adopt AI. Before Patlytics, she was an IP litigator at Steptoe, appearing before federal district courts, the Federal Circuit, and the PTAB. Her work includes representing Sandoz in a patent suit that ended in a Federal Circuit reversal of a $39 million jury verdict. Candice holds a B.S. in Biology from Stanford University and a J.D., cum laude, from the University of Illinois College of Law.
Josephine joined Patlytics from Bloomberg Intelligence, where she used patent data to deliver investment research and strategic insights. She brings more than 10 years of patent prosecution experience at Morrison Foerster, Jones Day, and Cooley, and helps life sciences and pharmaceutical companies integrate AI across the patent lifecycle.